ATAI Competitors & Alternatives
Compare ATAI Life Sciences BV with similar stocks in the same industry
Biotechnology
ATAI
Main Stock$4.09
Tradestie Score
52
Market Cap
$1.22B
Revenue Growth
-0.4%
Analyst Upside
+242.3%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VCEL
Vericel Corporation
|
$35.40
|
$1.56B | 80.2 | 57 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$88.72
|
$1.55B | - | 55 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$31.38
|
$1.55B | 12.3 | 66 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$29.45
|
$1.55B | - | 51 | Compare |
|
NVAX
Novavax Inc
|
$9.27
|
$1.54B | - | 59 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.90
|
$1.50B | 7.2 | 59 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$36.87
|
$1.50B | - | 59 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$13.61
|
$1.49B | - | 53 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$23.74
|
$1.43B | - | 54 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$14.40
|
$1.42B | - | 56 | Compare |
More ATAI Analysis
Data updated: May 20, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry